Based on the STAYBLE THERAPEUTICS AB stock forecast from 0 analysts, the average analyst target price for STAYBLE THERAPEUTICS AB is not available over the next 12 months. STAYBLE THERAPEUTICS AB’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of STAYBLE THERAPEUTICS AB is Bearish, which is based on 1 positive signals and 5 negative signals. At the last closing, STAYBLE THERAPEUTICS AB’s stock price was EUR 0.04. STAYBLE THERAPEUTICS AB’s stock price has changed by +2.93% over the past week, -33.04% over the past month and +3.48% over the last year.
No recent analyst target price found for STAYBLE THERAPEUTICS AB
No recent average analyst rating found for STAYBLE THERAPEUTICS AB
Company Overview STAYBLE THERAPEUTICS AB
Stayble Therapeutics AB (publ) develops injectable treatment for chronic pain triggered by disc degeneration. The company develops STA363, an injection into the disc that targets chronic low back and leg pain. Stayble Therapeutics AB (publ) was incorporated in 2015 and is based in Gothenburg, Sweden. Read Less
Stayble Therapeutics AB (publ) develops injectable treatment for chronic pain triggered by disc degeneration. The company develops STA363, an injection into the disc that targets chronic low back and leg pain. Stayble Therapeutics AB (publ) was incorporated in 2015 and is based i...Read More
Frequently Asked Questions About STAYBLE THERAPEUTICS AB (4K4:F) Stock
Stock Target Advisor's fundamental analysis for STAYBLE THERAPEUTICS AB's stock is Bearish.
Unfortunately we do not have enough data on 4K4:F's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 4K4:F's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 4K4:F's stock to indicate if its overvalued.
The last closing price of 4K4:F's stock was EUR 0.04.
The most recent market capitalization for 4K4:F is EUR 2.22M.
Unfortunately we do not have enough analyst data on 4K4:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains STAYBLE THERAPEUTICS AB's stock.
As per our most recent records STAYBLE THERAPEUTICS AB has 2 Employees.
STAYBLE THERAPEUTICS AB's registered address is Lennart Torstenssonsgatan 6, Gothenburg, Sweden, 412 56.
You can get more information about it from STAYBLE THERAPEUTICS AB's website at https://www.staybletherapeutics.se.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About STAYBLE THERAPEUTICS AB (4K4:F) Stock
Stock Target Advisor's fundamental analysis for STAYBLE THERAPEUTICS AB's stock is Bearish.
Unfortunately we do not have enough data on 4K4:F's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 4K4:F's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 4K4:F's stock to indicate if its overvalued.
The last closing price of 4K4:F's stock was EUR 0.04.
The most recent market capitalization for 4K4:F is EUR 2.22M.
Unfortunately we do not have enough analyst data on 4K4:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains STAYBLE THERAPEUTICS AB's stock.
As per our most recent records STAYBLE THERAPEUTICS AB has 2 Employees.
STAYBLE THERAPEUTICS AB's registered address is Lennart Torstenssonsgatan 6, Gothenburg, Sweden, 412 56.
You can get more information about it from STAYBLE THERAPEUTICS AB's website at https://www.staybletherapeutics.se.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 4K4:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
